Sign in
4

Changes in Ownership

Design Therapeutics, Inc. Filed Acc 0001209191-21-024224

Director bought 700,000 shares at $20.00 ($14,000,000)

  • Director acquired 2,032,501 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
William Arsani Director 2021-03-30 Conversion +1,217,627 1,217,627 I: show line 1 in the form
William Arsani Director 2021-03-30 Conversion +814,874 2,032,501 I: show line 2 in the form
William Arsani Director 2021-03-30 Purchase +700,000 $20.00 $14,000,000 2,732,501 I: show line 3 in the form
Open-market purchases · 700,000 sh · avg $20.00 · $14,000,000

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
William Arsani Director 2021-03-30 Conversion · Series B Preferred Stock −1,984,733 0 I: show line 4 in the form
William Arsani Director 2021-03-30 Conversion · Series B Preferred Stock −1,328,245 0 I: show line 5 in the form
Loading xslF345X03/doc4.xml…